Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

G
G Barillari	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
G Tagariello	-	Pegylated Interferon and Ribavirin Anti-hepatitis C Therapy in Patients with Hemophilia Is as Effective and Safe as in Non-hemophilic Patients
G Jayandharan	-	Thirty Novel Mutations in the Factor VIII Gene of Indian Patients with Haemophilia A
Gabazza EC	-	Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation
Gabi K	-	Preoperative Fibrin Monomer in Elective Surgery Predicts Intraoperative Blood Loss and Hospitalization Time: Results from a Confirmatory Study
Gabriel DA	-	FIX Activation on the Surface of Activate Platelets by rFVIIa in the Absence of Tissue Factor
Gachet C	-	Two-Phase Antithrombotic Protection after Anti-GPVI Treatment in Mice
	-	Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times
	-	Distinct Roles for the Type I PI 3-Kinases, p110b and p110g, in ADP-Stimulated Platelet Activation
	-	Role of the Platelet P2Y1 Receptor in Thrombus Formation Under Flow Conditions
Gachet C	-	Platelet P2Y and P2X Receptors
Gachet C	-	Interaction of Calmodulin with the Platelet ADP Receptor P2Y₁
Gadelha TB	-	807C/T Polymorphism in the Platelet Glycoprotein Ia Gene in Patients with Ischemic Stroke (IS) of Undetermined Etiology
Gadisseur A	-	Characterisation and Classification of Von Willebrand Diseases
Gaffney PJ	-	Slow Lysis of Porcine Blood Clots Is Caused by Resistance of Plasminogen to Activation
Gafou A	-	References Values of roTEM Instrument
Gagnon D	-	The 80+ Hemorrhagic Cohort Study – Rates, Severity and Predictors of Major Hemorrhage in a Cohort of Anticoagulated Atrial Fibrillation Patients
Gähler A	-	Preoperative Fibrin Monomer in Elective Surgery Predicts Intraoperative Blood Loss and Hospitalization Time: Results from a Confirmatory Study
Gaidarov B	-	Treatment of Congenital Coagulation Disorders in Countries with Limited Financial Resources – Bulgarian Experience
Gaikovaya L	-	The Role of Low Doses Anti-TNF In Improvement of Immune Function in PAD Patients after Late Thrombosis
Gailani D	-	Role of Residue 192 in Development of the Oxyanion Hole and in Macromolecular Specificity in Serine Proteases: Importance of Lys554 (192 in Chymotrypsin Numbering) in Factor XIa Catalysis
	-	Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo
	-	Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
	-	Role of Residue 193 in Development of the Oxyanion Hole in Serine Proteases: Kinetic Studies of the Effect of Side Chain Length and Charge in Factor XIa
	-	Factor XI Deficient Mice Have Reduced Platelet Accumulation and Fibrin Deposition after Laser Injury
Galanakis DK	-	Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
Galar M	-	von Willebrand Factor and Thrombomodulin in Patients with Thromboangiitis Obliterans
	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Acute Myeloid Leukaemia (AML)
Galar M	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Obliterative Atherosclerosis
Gale AJ	-	Disulfide Bond-Stabilized Factor VIII Mutants Demonstrate Improved Potency in Whole Blood FVIII-Sensitive ROTEG Assay
Galea B	-	How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals?
Gallagher J	-	New Insights into Heparin Binding and Activation of Heparin Cofactor II
Galli M	-	A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves
Galli M	-	Prevalence and Clinical Significance of IgG and IgM Anti-Protein S (aPS) and Anti-Annexin V (aAV): Retrospective and Prospective Analysis of the WAPS Study
Galli M	-	Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis
Galli M	-	Testing for Anticardiolipin Antibodies and Anti-Beta2-Glycoprotein I. Is It Useful? A Scientist's Perspective
Galli M	-	D-Dimer and the Risk of Venous Thromboembolism in Medical Patients
Galli M	-	Clinical Significance o IgG and IgM Anti-Phospholipid (aPL), Anti-Beta2-Glycoprotein I (aBeta2GPI), and Anti-Prothrombin (aPT) Antibodies: Retrospective and Prospective Analysis of the WAPS Study
Gallimore MJ	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) has Different Effects on Fibrinolysis Induced by Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) in a Whole Blood Thromboelastography Model
	-	Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation
	-	Whole Blood and Plasma ‘Thrombus Generation’ Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential
	-	The Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) Induced Fibrinolysis in a Plasma Clot Lysis Assay
	-	The Effect of Corn Trypsin Inhibitor on Whole Blood Thrombin and Thrombus Generation Parameters
Gallinaro L	-	FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
	-	How von Willebrand Factor Survival Contributes to Determining von Willebrand Disease Phenotype
Gallo L	-	An Innovative Method to Measure von Willebrand Factor Activity and Adamts13
Gallo N	-	A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
Gallotta G	-	Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary
Gallus AS	-	Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment
	-	Risk Factors for VTE In Patients Undergoing Abdominal Surgery: Lessons from the PEGASUS Trial
Gallus A	-	High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
	-	Heparin-Induced Thrombocytopenia (HIT) and Danaparoid (Orgaran^®): Review of 1479 Reported Clinical Outcomes of Patients Treated Between 1981 and 2004
	-	Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis
Gallus AS	-	Effect of Blood Salvage and Re-infusion on VTE Complications in Patients Undergoing Elective Major Orthopedic Surgery
Gallus A	-	An Audit on D-dimer Use in the Assessment of Patients with Suspected Acute Pulmonary Embolism
	-	Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
Gallus AG	-	Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis
Gallus A	-	Prophylaxis in Non-Surgical Patients
Gallus A	-	Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
Galton DJ	-	Risk Factors for Central Retinal Vein Occlusion
Galy-Fauroux I	-	Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells
Gamberalle¹ R	-	Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets
Gamberini M	-	Effects of Leptospiral Proteins on Human Endothelial Cells
Gamble JR	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Gamzatov T	-	The Role of Low Doses Anti-TNF In Improvement of Immune Function in PAD Patients after Late Thrombosis
Gan TE	-	Comparing Subcutaneous Low Molecular Weight Heparin (Dalteparin) Versus Intravenous Unfractionated Heparin in the Treatment of Acute Sub-massive Pulmonary Embolism: An Open Randomised Trial
Gan A	-	Developmental Haemostasis and Response to Heparin Therapy in Children
Gan TE	-	An Evaluation of the New ACL TOP Coagulation Autoanalyser
Gan A	-	Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU)
	-	Heparin Monitoring During Haemodialysis in Children
	-	Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis
Gan TE	-	The Development of a Protocol for Lepirudin Therapy Monitoring
	-	Evaluation of Diamed ID-PaGIA Heparin/PF4 Antibody Test for the Diagnosis Of HITTS
Ganapathy P	-	Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD)
Ganderton T	-	Thrombospondin as a Regulator of von Willebrand Factor Multimer Size
Gandini G	-	Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A
Gando S	-	A Prospective Comparison of New Japanese Criteria for Disseminated Intravascular Coagulation. New Japanese Criteria vs. ISTH Criteria
Gandrille S	-	Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions
Gane P	-	Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM
Ganesan V	-	Recurrent Stroke: The Role of Prothrombotic Disorders
Gangadharan B	-	High-Level Expression of Porcine Factor VIII from Genetically-Modified Bone Marrow-Derived Cell Types
Ganjanakarn E	-	Spontaneous Subgaleal Hemorrhage in a Girl with Adrenaline Receptor Defect
Ganser A	-	Rotation Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy
	-	Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
	-	Therapeutic Monitoring Using Rotation Thromboelastometry in Patients with Coagulation Factor VIII Inhibitors
Gao WQ	-	The Association of Arterial Thrombosis and Polymorphisms of Platelet Glycoproteins and von Willebrand Factor in the Chinese Population
GAO W	-	A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity
Garancini P	-	Association of High Lipoprotein(a) and Fibrinogen Levels Predicts Coronary Heart Disease and Cerebro-vascular Mortality in an Elderly (>=65 years) Northern Italian Population
Garcia ML	-	Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment
Garcia N	-	Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content
Garcia A	-	Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
Garcia ML	-	Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes
Garcia A	-	Erk–Mediated Thromboxane A2 Production Is Essential for von Willebrand Factor/GPIb–Induced Fibrinogen Receptor Activation in Human Platelets
Garcia RA	-	Effects of Warfarin Administration on in vivo Revascularization in a Rat Model of Hindlimb Ischemia
Garcia JF	-	Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial
Garcia ML	-	Natural Anticoagulation Evaluation in Type 2 Diabetes
Garcia AA	-	Influence of ABO Blood Group on the Collagen-Binding Assay
Garcia D	-	A Randomized Trial Comparing 1 mg Oral Vitamin K with Placebo for the Treatment of Warfarin-associated Coagulopathy in Patients with Mechanical Heart Valves
Garcia AA	-	Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease
Garcia JCF	-	Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
Garcia D	-	D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius
García De La Torre I	-	Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis
Garcia de Lorenzo A	-	Current Transfusion Practices in two Autonomous Regions in Spain: Castilla La Mancha and Extremadura. Results from the Spanish Critical Care Society Hemoderivatives Working Group
García-Barberá N	-	Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
	-	Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
Garcia-Talavera J	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Gardiner E	-	Regulation of Platelet Receptors
Gardiner C	-	A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing
Gardiner C	-	Implementation of a Telematic Homecare Platform for Oral anticoagulant Management
Gardiner E	-	Glycoprotein (GP) VI Is Associated with GP-Ib-IX-V on the Membrane of Resting and Activated Platelets
	-	Regulated Shedding of Platelet Receptors Glycoprotein VI and Glycoprotein Ib
Gardner A	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Garewal G	-	Prevalence of Risk Factors for Venous Thromboembolism: A Study from North India
Garghetti E	-	Evaluation of the New ACL TOP Coagulation Analyser from IL
Gari MA	-	Prevalence of Genetic Risk Factors Causing Thrombophilia in Normal Population and Recurrent Abortions Patients in Saudi Arabia
Garin G	-	An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions
Garin Gwen	-	Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells
Garner SF	-	GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains
Garo F	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Garrard CS	-	Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia
Garth S	-	Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis
Gartner TK	-	Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
Gary EG	-	Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets
Gasem MH	-	Coagulation Disorders in Severe leptospirosis in Indonesia
Gaspar L	-	Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
Gast MCW	-	Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
Gattens M	-	Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment
Gatti S	-	Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
Gatzemeier U	-	Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
Gaudin P	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
Gaus K	-	Relationship of Lipid Rafts and the Platelet Cytoskeleton
Gaussem P	-	The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses
	-	The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers
Gavalaki M	-	CoaguChek S Accuracy And Reproducibility in Comparison with the BCS Analyzer: Results in an Outpatient Anticoagulation Clinic
Gavasso S	-	Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
	-	Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects
	-	Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
	-	Cerebral Sinovenous Thrombosis in Children
	-	Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (‘Parahaemophilia’): Report of a Novel Homozygous Mutation (FV: Asp524His)
	-	Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study
Gavasso G	-	Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study)
Gavazova S	-	Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Gavornik P	-	Hyperbaric Oxygen Therapy in Chronic Non-Healing Diabetic and Venous Ulcer
Gawaz M	-	Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque
	-	Reduced Platelet Adhesion, Attenuated Atherosclerosis and Increased Resistance to Focal Cerebral Ischemia in Mice Lacking GPIIb Integrin
	-	Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood
Gay V	-	Intracerabral Hematoma and Congenital Afibrinogenemia
Gayen-Betal S	-	Heparin Is a Multifaceted Anti-Adhesive Agent: Inhibition of Phosphatidylserine (PS)-Positive Erythrocyte Binding to Matrix Thrombospondin (TSP)
	-	Confirmatory Evidence for the Presence and Functional Activity of a Phosphatidylserine Receptor (PSR) on Endothelial Cells
Gazzini A	-	Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
GC^1,2,3	-	Cellular Immune Responses in Hemophilia. Why do Inhibitors Develop in Some but not All Hemophiliacs?
Geary MP	-	The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Gebbink MFBG	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
	-	Glycation Induces Formation of Cross-b Structure and Activation of Tissue-Type Plasminogen Activator (tPA) and Factor XII
	-	The Interaction of Platelets-tumor Cell Complexes with Vitronectin
	-	Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System
	-	Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves
Geczy C	-	Heparin Selectively Inhibits CD11b High Affinity Neo-epitope Expression in vivo During Coronary Artery Bypass Surgery
Geczy CL	-	Serum Amyloid A (SAA) Induces Monocyte Tissue Factor
Geeraedts LMG	-	Transfusion of Blood Products in Trauma Patients with Lethal Hemorrhagic Shock
Geerts W	-	Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis
Geha RS	-	The WIP-WASp Complex Modulates Platelet Signaling and Function
Gehrisch G	-	Importance of the FV Level Screening for Individual Thrombotic Risk
Geil J	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Geisel J	-	Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
Geisen C	-	Genetic variants in COX 1-, GP Ia/IIb- and FXIIIa-subunits: Effects on Response to Aspirin in Patients with Peripheral Arterial Occlusive Disease
Geisen C	-	Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations
Geisen C	-	Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
Geisen U	-	Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Geisen C	-	A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses
Geisen P	-	Rap1b Is Required for Normal Blood Vessel Formation in Mice
Geisen C	-	First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency
Geiter S	-	TECHNOZYM^® ADAMTS 13 Assays for Analyzing the vWF Cleaving Protease ADAMTS 13
	-	Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
Gelmont D	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
Gemmati D	-	Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers
Gemmati D	-	CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction
Gemmell R	-	Evaluation of DiaMed Heparin/PF4 Testing for HIT
Genereux MG	-	Anti-D Compared to IVIg for the Treatment of Immune Thrombocytopenic Purpura: A Systematic Review
Geng Y-J	-	Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
Geng J	-	Therapeutic Inhibition of Endothelial Tissue Factor Expression by Nitric Oxide and Other Agents in Sickle Transgenic Mice
Geng Y-J	-	Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
Geng J-G	-	NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives
Gennari LC	-	Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies
Gensini GF	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
	-	Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
	-	Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study
	-	Vitamin B6 Serum Level and Inflammation and in the InChianti Study
	-	MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
	-	Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
	-	eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms
	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
	-	Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
	-	The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective Case–Control Study
	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
	-	Managed Hemostasis ‘Point-Of-Care’ Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests
	-	Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes
	-	Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
	-	Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
	-	Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
	-	Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
	-	Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk
	-	Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
	-	More Carotid Atherosclerosis in HCV Positive Italian Patients?
	-	Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes
	-	High Risk of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism
	-	Warfarin Therapy in AF Patients: Females Are Still at Risk
	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
Gensini F	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Gensini GF	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
	-	Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery
Gensini F	-	C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
Gensini GF	-	C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
	-	Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
	-	ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm
Gent M	-	Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
Gent YJJ	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
Gent M	-	Risk Factors for VTE In Patients Undergoing Abdominal Surgery: Lessons from the PEGASUS Trial
	-	An Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study
	-	Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
	-	Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials
	-	Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study
Gentilomo C	-	Cerebral Sinovenous Thrombosis in Children
Gentry HR	-	Crystal Structure of CIB1, an Endogenous Inhibitor of Platelet Integrin aIIbb3 Activation: Delineation of a New Family of Calcium-Binding Proteins
George B	-	Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate^®DVI
George MR	-	Pediatric Reference Intervals for Five Coagulation Assays
George B	-	Molecular Characterization of Haemophilia B: 17 Novel Mutations in Patients of Indian Origin
George J	-	An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura
George MW	-	Protein S Multimers are Generated in vitro and do Not Bind to C4b-binding Protein: Implications for Protein S Structure-Function Analysis
George J	-	Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells Indicated Heterogeneity of Subpopulations at Various Stages of Differentiation
	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Gera R	-	The Older Hemophilia Patient with Inhibitors: Issues and Challenges
Gerard B	-	Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Gerard RD	-	Tissue Factor Pathway Inhibitor-2 Inhibits in vitro Endothelial Cell Migration and Angiogenesis
Gerasimidis T	-	Whole Blood Tissue Factor Triggered Thromboelastography. A Sensitive Assay for the Monitoring of Anticoagulant Effect of LMWH after Stenting in Patients with Carotid Artery Disease
	-	Antiplatelet Treatment Does Not Affect the Kinetics of Clot Formation After TF Pathway Activation in Patients with Carotid Artery Disease. A Thromboelastography Study
Gercovich D	-	Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII
	-	Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII
Gerdes VEA	-	Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study
Gerdes V	-	Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis
	-	What Is the Real Contribution of Standardized Pre-test Clinical Probability Scores and D-dimer Assays to the Diagnostic Management of Deep Vein Thrombosis? Systematic Review of Clinical Outcome Studies
Gerdes VEA	-	Pentraxin 3 in Patients with Pulmonary Embolism
Gerdes V	-	Value of D-dimer, for the Exclusion of Deep Venous Thrombosis, in Different Pre-test Clinical Probability Categories
Gerdes VEA	-	The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia
	-	Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
	-	Prognostic Value of Echocardiography and Chest Computed Tomography in Patients with Pulmonary Embolism
Gerenli M	-	The Relationship between Pro-Inflammatory Cytokine Levels and Fibrinolytic System in Simple Obese Patients
Gerhard D	-	Role of FcRg and FXIII in Coated Platelet Formation and Platelet Procoagulant Activity in Mice
Gerhardt A	-	The IVS1-401 T-Allele of the Estrogen Receptor (ER)-a is an Independent Predictor of Late Fetal Loss
Gerhardt A	-	The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia
	-	Anticoagulation with Danaparoid in Two Pregnant Women with Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT Typ II)
Gerhardt A	-	Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism
	-	New Approach for Evaluation of Quantitative Risk Factors of Venous Thromboembolism Using Individualized Reference Values
Gerhardt A	-	Premature Onset of Fetal Loss Is Associated with the Polymorphism of Platelet Membrane Integrin a₂b₁ (a₂807TT)
Gerland V	-	Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor
Germer M	-	Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
	-	Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays
Gerotziafas GT	-	Effect Of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – on Clot-Bound Factor Xa Activity in vitro
Gerotziafas GT	-	The Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation
Gerrits WBJ	-	Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
Gershkovich KB	-	Activation Kinetics of Glycoform of GLU-Plasminogen and Lys-Plasminogen by Plasmin-Staphylokinase Complex
Gerstle T	-	Antiphospholipid Syndrome Secondary to Renal Cell Carcinoma in a Twelve year Old Boy
Gessner R	-	Drugs with Anti-Prion Activity in Cell Culture Have Variable Effects on the Stimulation of Plasmin Generation by the Prion Protein NH₂-terminal Fragment PrP23-110
Gestel D	-	The Contribution of Somatic Mutations in an Antibody against Factor VIII to the Kinetics of Factor VIII Binding and Inhibition of Factor VIII Activity
Gevaert K	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Gevenois PA	-	Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
Gevers T	-	Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients
Ghaly M	-	Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk
Ghamari A	-	Study of Genetic Risk Factors for Cardiovascular Disease in the Iranian Population by Means of Reverse-Hybridization Teststrips
Ghanima W	-	A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients
Gharavi AE	-	Induction of Tolerance to b₂Glycoprotein I in Mice
Ghaznawi F	-	Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation
Ghent T	-	Queensland Health Pathology Service Statewide Coagulation Quality Control Database: the First Three Years Experience
Gheorghiu E	-	Thrombotic Risk in a Romanian Family with Protein S: Deficient Members
Ghevaert C	-	There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation
Ghevaert C	-	Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera
Ghezzi F	-	Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study
Ghezzi A	-	Modified Antiplatelet Action of Atorvastatin in 3'UTR/T LOX-1 Polymorphism Carriers
Ghiotto R	-	In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency
	-	Eight Novel Mutations in FXI Gene
	-	Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation
Ghirarduzzi A	-	Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL)
Ghirarduzzi A	-	Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
	-	The Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism. A Multicentre Prospective Cohort Study in 1626 Patients
	-	Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls
	-	Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
	-	The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
	-	Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics
Ghosh K	-	Prevalence of Thrombophilic Mutations and Polymorphisms in Cases of Recurrent Pregnancy Loss (RPL)
	-	VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population
	-	Prevalence of type 2N von Willebrand Disease in Indian VWD patients
	-	Thrombophilia Markers in Cases of Inflammatory Bowel Disease (IBD)
Giacomelli S	-	Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study
Gianelli U	-	Endothelial Protein C Receptor Is Expressed by CD83⁺ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells
Giangrande P	-	A Postmarketing Study of the Safety and Efficacy of ReFacto^® in Haemophilia a Patients
	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
Giannarelli C	-	Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature
Giannarelli C	-	‘Spontaneously Acquired Factor VIII and IX Inhibitors in a Patient with Sjogren Syndrome’
Gianniello F	-	Long Term Prophylaxis of Bleeding Episodes in Patients with von Willebrand Disease: Efficacy and Safety of Factor VIII/von Willebrand Factor Concentrates
Giansily-Blaizot M	-	Prenatal Diagnosis in a Lebanese Family with Severe Factor VII Deficiency
Giansily-Blaizot M	-	A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX
Giarratano A	-	Objective Assessment of Pulmonary Embolism Can Be Deferred without Risk
Gibb CB	-	Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
Gibb S	-	A Negative Venous Duplex Ultrasound Scan Alone Excludes Deep Venous Thrombosis in Clinical Practice
Gibbins JM	-	Platelets Act as Targets for Newly Identified Peripheral Tachykinins
	-	Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
	-	Platelet Nitric Oxide Synthase (NOS) Is Negatively Regulated by Tyrosine Phosphorylation: A Novel Mechanism of eNOS Regulation
Gibbs H	-	The Use of Temporary IVC Filters for the Prevention of Pulmonary Embolism in High Risk Patients
	-	A Negative Venous Duplex Ultrasound Scan Alone Excludes Deep Venous Thrombosis in Clinical Practice
Gibson NS	-	Prognostic Value of Echocardiography and Chest Computed Tomography in Patients with Pulmonary Embolism
Gibson NS	-	Pentraxin 3 in Patients with Pulmonary Embolism
Gibson C	-	Role of Plasma Exchange (PE) in the Treatment of Transplant-Associated Thrombotic Microangiopathy (TM)
Giddings J	-	Detection of Decreased GPIb Alpha Expression Using an Improved Flow Cytometric Assay in Pateints with an Inherited Macrothrombocytopenia and a Mild Clinical Phenotype
Giddings JC	-	Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT)
	-	Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice
	-	Clinical Measurements of Platelet Activation by Flow Cytometry Under Optimised Conditions
Giese CH	-	Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin
	-	Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
Giese, Ch, Fenyvesi T	-	In-vitro Reversal of Anticoagulant Effects of Specific Factor Xa and Thrombin Inhibitors
Giese, Ch, Weiss, Ch	-	Inhibition of Thrombin Generation by Warfarin
Giesler U	-	Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation
Giglioli C	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Protein Z Plasma Levels in Different Phases of Activity of Coronary Atherosclerosis
	-	Antiaggreganting Agents Do Not Influence the Sonoclot Profile
	-	High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study
Gijzen KA	-	Protein Kinase A-dependent Clustering of Weibel-Palade Bodies in Endothelial Cells
Gilbert GE	-	Antibody to C1 Domain of Factor VIII Alters Interaction of Factor Xase Complex with Factor X
Gill J	-	Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Gille J	-	Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis
Gillen J	-	The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Gilles JG	-	Anti-idiotypic Monoclonal Antibodies (Anti-Id mabs) Neutralizing Anti-FVIII Antibodies (abs) Directed Towards Heavy and Light Chains Fully Protect FVIII Function
Gilmore G	-	Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates
Gilmore G	-	Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial
Gils A	-	Characterization of ELISA's Exclusively Reacting with TAFI, the Released Activation Peptide from TAFI and Activated TAFI Using an in vitro Clot Lysis Assay
	-	Construction and Characterization of MA-T94H3 Derivatives, a TAFI Neutralizing Antibody
	-	Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation
	-	A Rational Approach For Stabilization Of Activated TAFI (TAFIa)
	-	Expression and Characterization of Rat TAFI
Ginsberg JS	-	Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
	-	Derivation of a Clinical Model to Predict the Likelihood of Recurrent Deep Vein Thrombosis
	-	Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
	-	Evaluation of the Relationship between Free Protein S Levels and Thrombin Generation during Pregnancy
Ginsburg D	-	Recombinant ADAMTS13 Refractory to Suppression by TTP Inhibitors
	-	Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice
	-	An Endothelial Cell-specific Regulatory Mutation In Galgt2 Is the Major Cause of Prolonged aPTT in Mice
	-	Additional Environmental and Genetic Factors Are Required to Trigger TTP in ADAMTS13-Deficient Mice
Ginsburg D	-	Identifying Novel Genetic Determinants of Hemostatic Balance
Giordano L	-	Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats
Giordano P	-	Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations?
Giordano KF	-	The Impact of Symptom Duration on Plasma Fibrin D-Dimer Analysis in Deep Vein Thrombosis
Giordano P	-	Hemostatic Alterations in Pediatric Leukemias
	-	Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment
Giordano G	-	Leukocyte Activation in Myeloproliferative Disease
Girard P	-	Diagnostic Value of D-Dimer Assay in Patients with Suspected Pulmonary Embolism: Results in a Multicentre Outcome Study, the ESSEP Study (Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire)
Girard P	-	Deep Venous Thrombosis in Patients with Acute Pulmonary Embolism: Prevalence, Risk Factors and Clinical Significance
Girard P	-	Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study
Girard P	-	Is It Safe to Withhold Anticoagulant Therapy in Patients with Negative Results on Spiral CT Pulmonary Angiography?
Girardi G	-	A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis
Giraud Carole	-	Evaluation of a Fully Automated Immuno-Turbidimetric Assay to Quantify Free Protein S (HemosIL Free Protein S)
Girelli D	-	Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
Girelli D	-	Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project
Girisch M	-	Failure of Anticoagulation in Kawasaki Disease
Girndt M	-	Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
Girolami A	-	High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency
	-	Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases
Girolami B	-	Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases
Girolami A	-	Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study
Girolami A	-	Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases
Girolami B	-	Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases
Girolami A	-	Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
	-	Non-Catheter Induced Venous Thrombosis in Haemophellia A E B Patients
Girolami A	-	Oral Contraceptives in the Management of Rare Coagulation Bleeding Disorders
Girolami A	-	Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency
Girtovitis F	-	HIT-II: Therapeutical Use of Fondaparinux (Our Experience)
	-	Thrombophilic Mutations: A Comparison between the Microarray Technique and the Solid Phase Oligonucleotide Ligation Assay (SPOLA)
	-	Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs
	-	The Possible Protective Role of FXIII Leu34 Allele in Thromboembolic Episodes. Its Coexistence with FVL and PAI-1 (4G/5G) Mutations in Thrombophiliacs
	-	Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro
	-	Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT)
	-	An Inquiry into Death Causes Based on Autopsy Findings
Gissel MT	-	Activity and Content of Factor VIII in Various Factor VIII Products
Gissen P	-	Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family
Gitel S	-	Platelet Mediated Clot Formation in Whole Blood under Flow: A New Screening Method for Coagulation Disorders and for Drug Monitoring
Giuliano V	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Giuseppe T	-	Inhibitor Development in Previously Untreated or Minimally Treated Patients with Hemophilia a Treated with a Plasma-derived Solvent-detergent Factor VIII Concentrate
Giusti B	-	Vitamin B6 Serum Level and Inflammation and in the InChianti Study
	-	C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
Giusti B	-	Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
Giusti C	-	Determinants of Platelet Activation in Alzheimer's Disease
Giustolisi R	-	Recurrent Symptomatic Thrombotic Stroke in Patients with Patent Foramen Ovale and Prothrombin A20210 Mutation or FV Leiden as Potential Thrombophilic Risk Factors
	-	Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders
	-	Evidences for Vascular Endothelium Damage/Proliferation and Abnormal Neoangiogenesis by Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin-6 (IL-6) Increased Levels in Sickle Cell Disease
	-	Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk
	-	First Line Therapy with FEIBA^® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors
	-	Recurrent Venous Thromboembolic Events during Treatment with Combined Oral Contraceptives in Hereditaria Dystrophic Epidermolysis Bullosa
Gizzi S	-	Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Gladysheva I	-	Pro-Fibrinolytic Monoclonal Antibodies That Convert a2-Antiplasmin from a Plasmin Inhibitor to a Substrate
Glenn JR	-	Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39
Glenn JR	-	Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y₁ and P2Y₁₂ Receptors
	-	Contributions of Blood Cells to Adenine Nucleotide Metabolism
Glowczynska R	-	Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
	-	Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
Gnatenko DV	-	Platelets Express Steroidogenic 17b–hydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype
Gnatenko D	-	PAR3 Expression and Functions Studied with Blocking, Cleavage Site-Specific Antibodies
Gnau O	-	Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
	-	Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
Goda T	-	Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome
Goecke TW	-	The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia
Goemans N	-	Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients
Goglidze I	-	Hereditary Thrombophilia is not a Risk Factor for Idiopathic Retinal Vein Thrombosis
Gokoz G	-	Thrombosis in Cancer Patients
Gokudan S	-	Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors
Golanski J	-	Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function?
Gold SH	-	Recurrent Hemarthroses Halted by Sequential Therapy with Activated Prothrombin Complex Concentrate (aPCC) and Recombinant Factor VIIa
Goldberg RJ	-	Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
Goldenberg NA	-	Survival and Thromboembolic Outcomes of Septic Jugular Vein Thrombosis (Lemierre's and Lemierre-Like Syndromes) in Children
	-	Clinical Application of the Clot Formation and Lysis (ClofAL) Assay to Physiologic and Pathologic Changes in Factor VIII
Goldshmidt O	-	Effect of Heparanase on TF Expression and TFPI Release
Goldsmith G	-	Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion
Goldsmith R	-	A System to Track Coagulation Factor Concentrates Can Decrease Waste
	-	Telephone Consultation Provided by the Hemophilia Treatment Centre – A Significant Part of the Service
Golino P	-	Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes
Golovina OG	-	Differences in the VWF : Rico/VWF : Ag Ratios among Patients with Venous or Arterial Thromboses
Goltsova K	-	Homocystein and Hemostatic Variables in Young Postinfarction Patients
Golubeva M	-	The State of Fibrinolytic and Coagulation Systems in Hemophiliacs
Gomaa M	-	Platelet Functions and Markers of Platelet Activation in Coronary Artery Bypass Grafting (CABG) with or without Cardiopulmonary Bypass (CPB)
Gomes L	-	C4b-binding Protein (C4BP) Prolongs the Survival of Human Protein S in an Experimental Mouse Model
Gomes N	-	Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Huvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion
Gomez K	-	FVII Deficiency due to Homozygous FVII T324M Mutation
Gomez JG	-	Thrombophilia in a Healthy Population from Northwest Colombia
Gomez JM	-	Thrombophilia in a Healthy Population from Northwest Colombia
Gómez RM	-	Effects of Leptospiral Proteins on Human Endothelial Cells
Gomez RM	-	Regulation of Megakaryocyte Generation by Monocytes/Macrophages
	-	Cyclic AMP Protects Stem Cell (CD34⁺) Apoptosis
Gomez JM	-	Study of the Prethrombotic State in Patients at High Risk of Developing Type 2 Diabetes Mellitus
Gomez N	-	Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported
Gomez GEB	-	Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation?
Gomperts ED	-	Activity and Content of Factor VIII in Various Factor VIII Products
Goncalves I	-	Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury
Gonchar V	-	New Approach in Hemophilia a Treatment
Goncharov I	-	A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy
Gong X	-	Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization
Gonzales A	-	Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI)
González B	-	Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor
Gonzalez Vucovik M	-	Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation
González-Conejero R	-	Conformational and Functional Changes in Antithrombin by Oxidation
Gonzalez-Conejero R	-	Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder
	-	Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A₂ Level and might Affect the Efficacy of Aspirin
González-Conejero R	-	Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
Gonzalez-Conejero R	-	Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
González-Enríquez E	-	Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit
González-Conejero R	-	Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
	-	Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction
	-	Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage
	-	Pharmacogenetic Effect of Factor VII -323 Del/Ins Polymorphism on Diurnal Variation of Factor VII Coagulant Activity and INR in Steady Anticoagulated Patients with Atrial Fibrillation
Goodall AH	-	Differential Upregulation of Tissue Factor and Tissue Factor Pathway Inhibitor in Monocytes by Activated Platelets and Lipopolysaccharide
Goodall AH	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
	-	Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction
Goodall AH	-	Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
	-	Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
Goodall GJ	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Goodall AH	-	Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin
	-	Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography
	-	Comparison of the Procoagulant Activity of T-Lymphoblastoid Cells with Fresh Platelets in Three Phospholipid Dependent Assays
Goodall AH	-	Differential Contribution of P2Y₁ and P2Y₁₂ ADP Receptors to GPVI-Mediated Phosphatidylserine Exposure on Platelets and Microparticles
Goodeve A	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
Goodeve A	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Goodeve A	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Goodfellow KJ	-	Influence of Factor V Leiden and Lupus Anticoagulant on a New Venom-Based Clotting Assay of Protein C
Goodnough LT	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Goodwin C	-	Development of a Bifunctional Inhibitor with Anticoagulant and Anti-Platelet Activity
Gopinadhan M	-	The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Gorbacheva L	-	PARs (Protease Activated Receptors) Activation by Thrombin and Factor Xa Protects Hippocampal Neurons against Glutamate-induced Apoptosis
Gorbatenko A	-	Effects of Plasma Dilution with Crystalloid or Colloid Solutions on Blood Coagulation
Gore T	-	Cost-Effectiveness of Different Treatment Regimens Consisting of NovoSeven^® Versus FEIBA VH for the Home Treatment of Minor-to-Moderate Bleeds in Hemophilia Patients With Inhibitors in the United States: A Cost-of-Bleed Model
Gore JM	-	Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events
	-	Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
Gorelik R	-	Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function
Gori AM	-	Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
	-	Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
Gori AM	-	Vitamin B6 Serum Level and Inflammation and in the InChianti Study
	-	MTHFR C677T Polymorphism is Associated with Low Levels of Folic Acid in the InChianti Study
Gori AM	-	Inflammatory Markers are Associated with the Abdominal Aortic Diameter
	-	Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activable Fibrinolysis Inhibitor (TAFI) in Juvenile Deep Vein Thrombosis
	-	Prevalence of Inflammatory Gene Polymorphisms in Nonvalvular Atrial Fibrillation Patients
Gori AM	-	Platelet Function Predicts Myocardial Damage in Patients with Acute Coronary Syndromes Treated with Multiple Antiplatelet Agents
	-	Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
Gori AM	-	Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study
	-	Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study
Gori AM	-	Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
Goris M	-	Coagulation Disorders in Severe leptospirosis in Indonesia
Gorman R	-	High Shear Platelet Function Is Associated with Major Adverse Events in Patients with Stable Cardiovascular Disease (CVD) Despite Aspirin Therapy
Gorospe JR	-	Decreased Platelet Expression of MYL9 (Myosin Light Chain Regulatory Polypeptide) and Other Genes with Platelet Dysfunction and CBFA2 (AML1) Mutation: Insights From Platelet Expression Profiling
Gorp van ECM	-	Coagulation Disorders in Severe leptospirosis in Indonesia
Gorter G	-	Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
	-	Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2
	-	Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
	-	Down-regulation of Low-Density Lipoprotein-induced Platelet Signaling
Goschnick M	-	Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
	-	Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
Goshen G	-	Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone
Goss D	-	Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe
Gossage J	-	Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis
Gossage JA	-	Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
Gossage J	-	Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
Gosselin R	-	Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy
Gosselin RC	-	Prevalence and Clinical Utility of IgA Isotype Antiphospholipid Antibodies
Gosselin R	-	Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients
Gosselin R	-	Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score
Goto S	-	Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction
Goto S	-	R-138727, the Active Metabolite of Prasugrel (CS-747, LY640315), Inhibits Platelet Aggregation and Thrombus Formation under Blood Flow Conditions
Goto S	-	Role of Thrombin Formed on the Surface of Activated Platelets on the Three-Dimensional Growth of Platelet Thrombi Formed on the Collagen Fibrils under Blood Flow Conditions
	-	Antithrombotic Mechanisms Achieved by Selective Extraction of Cholesterol from Platelet Membrane by Methyl-b-Cyclodextrin
Gotoh M	-	Increased Levels of Hepatocyte Growth Factor in Patients with DIC
Goudemand J	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
Goudemand J	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Goudemand J	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Gough PJ	-	Macrophage Expression of Active MMP-9 Is Sufficient to Induce Plaque Rupture in ApoE–/– Mice
Gougopoulou D	-	How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals?
Gouin I	-	A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations
	-	We Still Need to Organize French Anticoagulation Clinics
Gould WR	-	Localization of Factor Va and Factor Xa Binding to Lipid Rafts in Human Platelets
	-	Factor Xa-Directed Inhibition in Plasma from Patients Undergoing Coumadin Treatment: Observations Relevant to Bridging Therapy
Gourdier AL	-	Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
Gouw SC	-	Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
	-	The Concerted Action on Neutralizing Antibodies in Severe Haemophilia A (Canal Study): Preliminary Findings
Gouw SC	-	Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
Govers-Riemslag JWP	-	Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography
	-	Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
	-	Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Goyal A	-	Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen?
Goycoolea M	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
	-	Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
	-	Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Gozal Y	-	Platelet-Derived Microparticles Induce Angiogenesis and Stimulate Post-Ischemic Revascularization
Grabarczyk K	-	Lack of Occult HBV Infection in Polish Haemophilia Patients
Gräber S	-	Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG
Grabowski EF	-	Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
Grabowski EF	-	Do Detached Endothelial Cells and Microparticles Contribute to the Procoagulant Activity Observed in Hemolytic Uremic Syndrome?
Grabowski M	-	Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
	-	Thienopyridines Pretreatment Decreases Long-Term Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines
Grabowski EF	-	Real-Time Imaging of Tissue Factor-Positive Microparticles in Flowing Blood
Gradwell DP	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
	-	Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography
Graffigna M	-	Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content
Grafos N	-	Activated Factor XI Cleaves von Willebrand Factor in the A2 Domain: A Possible Role of FXIa Along with ADAMTS13 in the Etiology of TTP
	-	ADAMTS13 Forms a Stable Complex with Coagulation Factors XI (FXI) and Activated FXI (FXIa): Quantitation of ADAMTS13/FXI Complexes in Normal Plasma and in Thrombotic Thrombocytopenia Purpura (TTP) Plasmas Using a New ELISA
Graham G	-	Platelets Act as Targets for Newly Identified Peripheral Tachykinins
Grailhe R	-	Haemostasis Is Regulated through Nicotinic Acetylcholine Receptors
Grailly S	-	Anti-idiotypic Monoclonal Antibodies (Anti-Id mabs) Neutralizing Anti-FVIII Antibodies (abs) Directed Towards Heavy and Light Chains Fully Protect FVIII Function
Gérald B	-	Is the Maternal anti HPA-1a Antibody Concentration a Useful Parameter for Antenatal Management of High-risk Pregnancies?
Gram J	-	Occurrence of Venous Thrombosis (VT) Is Not Increased in Women Taking Postmenopausal Hormonal Replacement Therapy (HRT) in the Danish Osteoporosis Prevention Study (DOPS)
	-	Reduced Fibrin Compaction and Increased Fibrin Formation Rate in Patients with End-Stage Renal Disease
Grancha S	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
	-	Optimisation of Ristocetin Cofactor Test for Low Activity Samples
Grandini A	-	CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction
Grandone E	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
	-	Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
	-	The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia
Granier C	-	Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII
	-	A Spot Peptide Approach to Identify Binding Regions Between the TF-FVIIa Complex and its Macromolecular Substrates FIX and FX
Grant PE	-	Massive Sinus Thrombosis in a Six-Year-Old Girl: Acute Management and Identification of a Possible New Hypercoagulable State
Grant PJ	-	Study Of TFPI T-287C Polymorphism in Relation to Venous Thrombosis; Association/Functional Analyses and Characterization of TFPI Promoter
Grant R	-	Tissue Plasminogen Activator (TPA) Therapy Resulting in Epidural Haemorrhage Following Intrathecal Therapy in a Pediatric Patient with Stage IV Burkitt's Lymphoma
Grant P	-	Atomic Force Microscopy Imaging of Fibrinogen on Different Surfaces: Implications for Implantation Materials Design
	-	Atomic Force Microscopy Imaging of Blood Coagulation Factor XIII in Its Native Form and in Fibrin Clot Formation
Grant PJ	-	Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen)
Grant A	-	Marginal Effect of Interference of Simvastatin on Clopidogrel Antiplatelet Effectiveness Assessed by Measures of Platelet Activation and Aggregation
Grant PJ	-	Characterizing the Plasma Clot Proteome
Grant RM	-	Antiphospholipid Syndrome Secondary to Renal Cell Carcinoma in a Twelve year Old Boy
Grant PJ	-	Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain
	-	Molecular Mechanisms Involved in the Resistance of Fibrin to Clot Lysis in Subjects with Type 2 Diabetes Mellitus
	-	Clustering of Adipokines and Haemostatic Factors: Evidence for Transcriptional Co-regulation
	-	A Proteomics Approach for the Identification of Plasma Transglutaminase (FXIII) Substrates
Grass L	-	Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases
Grassilli S	-	Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
Gravell D	-	Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman
Graw J	-	Comparison of B-Cell Epitope and Mutation Type in Haemophilia A Patients
Gray E	-	Protamine Sulphate Neutralization of Anti-Xa and APTT Activities of Low Molecular Weight Heparin Oligosaccharides
Gray E	-	Thrombin Generation under Flow Conditions in the Presence of Direct and Indirect Inhibitors of Factor Xa
Gray E	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
Gray E	-	Comparison of the Procoagulant Activity of T-Lymphoblastoid Cells with Fresh Platelets in Three Phospholipid Dependent Assays
Graybiel AM	-	CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
Greaves M	-	The Effects of Surgery on Platelet and Endothelial Function in Patients with Peripheral Arterial Disease and Severe Limb Ischaemia
	-	Evaluation of Aspirin Resistance in Peripheral Arterial Disease
	-	The Effects of Isometric and Treadmill Exercise on Platelet and Endothelial Function in Patients with Intermittent Claudication
	-	ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
	-	Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
	-	Altered Clearance of Apoptotic Endothelial Cells in the Presence of Antiphospholipid Antibodies Provides a Dual Mechanism for Thrombosis in Antiphospholipid Syndrome
	-	Coagulation Activation in Women with Hyperemesis Gravidarum
	-	Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
Grebe R	-	Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium
Greber S	-	Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography
Greco V	-	Assessment of Protein S on Hepatopaths at the Last Stage
Greco NJ	-	Factor VIIIa Regulates Substrate Delivery to the Intrinsic Factor X-Activating Complex
Green R	-	The Impact of Factor XIII Polymorphisms, FXIIIa T204P, P506L and Factor XIIIb Polymorphism H95A, on Myocardial Infarction
Green FR	-	Genetic Variation within the Interleukin 6 Promoter Determines Interleukin 6 Expression Levels in Atherosclerosis
Green D	-	Catastrophic Antiphospholipid Antibody Syndrome: Successful Treatment with Immunosuppresive Therapy and Plasmapheresis
Green FR	-	The b-Fibrinogen -1420G/A Promoter Polymorphism Influences Transcription through Differential Binding of FOXA/HNF3 and May Explain the Association of the -1420A-Containing Haplotype with Elevated Plasma Fibrinogen
Green D	-	Evolving Risk for Thromboembolism in Spinal Cord Injury
Green D	-	Fondaparinux Use in Heparin-Induced Thrombocytopenia
	-	Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency
Greenfield RS	-	Activated Factor XI Cleaves von Willebrand Factor in the A2 Domain: A Possible Role of FXIa Along with ADAMTS13 in the Etiology of TTP
Greenfield R	-	Does Human Semen Contain a Functional Haemostatic System? A Possible Role for Tissue Factor Pathway Inhibitor in Fertility through Semen Liquefaction
Greenfield RS	-	ADAMTS13 Forms a Stable Complex with Coagulation Factors XI (FXI) and Activated FXI (FXIa): Quantitation of ADAMTS13/FXI Complexes in Normal Plasma and in Thrombotic Thrombocytopenia Purpura (TTP) Plasmas Using a New ELISA
Greenfield R	-	Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen?
Greenfield RS	-	Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
Greenfield R	-	Quantitation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Human Semen
	-	Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease?
Greensmith H	-	Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
Greer IA	-	ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
	-	Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
Greer IA	-	Low-Molecular-Weight Heparins for Prophylaxis and Treatment of Venous Thromboembolism in Pregnancy: A Systematic Review of Safety and Efficacy
Gregor J	-	Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy
Gregorini L	-	Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation
Greinacher A	-	The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Greinacher A	-	A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status
	-	Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations?
Greinacher A	-	Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates
Greinstetter S	-	Combinatorial Peptides Directed to Inhibitory Antibodies against Human Blood Clotting Factor VIII
Grenner Y	-	Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
Gresele P	-	Deficiency of Matrix Metalloproteinase-2 (MMP-2) Impairs Platelet-Dependent Haemostasis in Mice
Gresele P	-	Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes
Gresele P	-	Detection of a Critical Degree of Platelet TxA₂-Production Inhibition by the PFA100 in Aspirin-Treated Subjects: Possible Relevance for the Monitoring of Aspirin Resistance
Gresele P	-	NCX-6550, a Nitric Oxide-Donating Derivative of Pravastatin, Prevents Thrombus Formation and Inhibits Intimal Thickening in Hypercholesterolemic Mice more than Pravastatin, Despite Identical Lipid Lowering
	-	Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study
	-	Evidence Suggesting That Activated Platelets Induce APC-Resistance in Vivo
Gres[scaron]ner P	-	Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of ‘Aspirin Resistance’?
Grezchnik E	-	Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
Griesshammer M	-	Pregnancy of a Libanese Woman with Homozygous Protein C deficiency
Griffin JH	-	Genotype Associations with Dyslipoproteinemia in Male Venous Thrombosis Patients
	-	Disulfide Bond-Stabilized Factor VIII Mutants Demonstrate Improved Potency in Whole Blood FVIII-Sensitive ROTEG Assay
Griffin B	-	A New Double Virus Inactivated 4-Factor Prothrombin Complex Concentrate (4F PCC)
Griffin JH	-	Modulation of Endothelial Protein C Receptor (EPCR)-Dependent Protein C Activation and Activated Protein C Cytoprotective Activity By Platelet Factor 4
	-	Venous Thrombosis in Males Is Associated with Dyslipoproteinemia Involving High Density Lipoprotein (HDL) Deficiency and Excess Low Density Lipoprotein (LDL)
	-	Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis
	-	Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
	-	Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
	-	Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation
Griffin JH	-	Activated Protein C
Griffioen A	-	Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease
	-	Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease
Griffith B	-	Neurologic Injury during Ventricular Assist Device (VAD) Support: Association with Rebound Hypercoagulability after Heparin Withdrawal
	-	Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients
Griffiths ABM	-	Phospholipid Correction of Prolonged Kaolin Clotting Times. Validating the Diagnosis of a Lupus Anticoagulant
	-	Are High Factor VIII Levels in Combination with High Fibrinogen Levels a Consistent Finding in Compromised Obstetric Cases Particularly Preeclampsia?
Grigorescu-Sido P	-	Associated Vitamin K Deficiency in Gaucher Disease Patients
Grigorjeva M	-	The State of Fibrinolytic and Coagulation Systems in Hemophiliacs
Grill DE	-	The Impact of Symptom Duration on Plasma Fibrin D-Dimer Analysis in Deep Vein Thrombosis
Grillari J	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Grimaudo S	-	Thrombophilia in Women with Unexplained Fetal Loss
	-	Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors
Grimsley A	-	Cellular Immune Responses in Hemophilia. Why do Inhibitors Develop in Some but not All Hemophiliacs?
Gringel E	-	Performance Evaluation of APC Resistance/FV Leiden Assay Applications on Routine Coagulation Analyzers
	-	Multicenter Evaluation of BCS^® XP – A Further Development of the Widespread BCS^® Coagulation Analyzer
Gringeri A	-	Quality of Life is Associated to Orthopedic Status in Hemophilic Patients with Inhibitors
	-	Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study
	-	Quality of Life in Patients with Haemophilia – An European Comparison Study (ESCHQoL)
	-	Health-related Quality of Life in Adult Patients with Haemophilia – Assessment with a New Disease-specific Questionnaire (Haem-A-QoL)
	-	Differences between Patients’, Physicians’ and Pharmacists’ Preferences for Treatment Products in Hemophilia. A Discrete Choice Experiment
	-	Assessment of Treatment Satisfaction in Patients with Haemophilia – Development and Validation of the First Disease-Specific Questionnaire (Hemo-Sat_A)
Gringeri A	-	Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
	-	The Cost of Care of Hemophilic Patients without Inhibitors: The Coche Study
Grinnemo KH	-	Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia
Gris JC	-	Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C
	-	The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched Case–Control ‘Big NOHA First’ Study
Grisaru D	-	Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation
Gritsch H	-	FEIBA – Mode of Action
	-	Stability of CEPROTIN, Human Protein C Concentrate, for Use in Continuous Infusion
Gritsenko PG	-	New Polymerization Sites in the Bb15–53 Fragment of Fibrin Molecule
Gritsenko PG	-	Molecular Composition of Soluble Fibrin at Various Diseases and Fibrinolysis Products Reacting with D-dimer-Specific Monoclonal Antibody III-3b
Gritti D	-	Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
Grizzi F	-	The In-Hospital Cost of Thrombosis: A Preliminary Economic Analysis
Groeschl M	-	Living with Morbus Glanzmann – A Case Report of a Now 20 Year Old Mother
Groeseneken T	-	Activation and Translocation of Tyrosine Phosphatase SHP-1 to Lipid Rafts Is P2X1 Mediated: Role in Collagen Induced Platelet Activation
Gröner A	-	Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
Groner A	-	Nanofiltration Removes Virus Infectivity But Not NAT/PCR Signal for a Wide Range of Viruses
	-	Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
Géronimi F	-	Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Gronowska A	-	Lack of Occult HBV Infection in Polish Haemophilia Patients
Groot de PhG	-	The Interaction of Platelets-tumor Cell Complexes with Vitronectin
Gros A	-	Usefulness of Thromboelastography (ROTEM^®) in Coagulation Management in Trauma Patient
Grosley M	-	A New Fully Automated Functional Assay for TAFI Determination – STA^® Stachrom^® TAFI
Gross PL	-	Atorvastatin Delays Thrombus Formation and Inhibits Leukocyte-Firm Adhesion to Thrombi Following Laser-Induced Arterial Injury in the Mouse
Gross C	-	Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) – a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM)
Gross PL	-	Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Negatively Influences Thrombus Formation in Vivo
Grossi P	-	The Risk of Venous and Arterial Thrombosis in Patients with HIV Infection
Grossmann R	-	Platelet CD40L in Chorioamnionitis
Grosso SH	-	Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease
Grosso S	-	Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies
Grosso S	-	Anti Factor VIII Inhibitor: A Single Institution Experience
Gruber G	-	Protein-Biochemical Characterisation of Wilate^®: Determination of the Upper Residual Moisture Limit during Terminal Dry-Heat Treatment
	-	Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate^®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment
	-	Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate
Gruber A	-	Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
Gruber G	-	Terminal Dry-Heat (TDH) Treatment, As Part of the Octanate^® Production Process, Contributes to the High Virus Safety Preserving the Structural and Functional Properties of the Concentrate
Gruel Y	-	Development of Non-pathogenic Antibodies to Platelet Factor 4 during Treatment by Fondaparinux after Hip Surgery
	-	Physiopathology and Diagnosis of Heparin-Induced Thrombocytopenia
	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Gruel Y	-	Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism
Grundt H	-	Changes in Concentration of Specific Forms of Activated Factor XII Are Observed Following Thrombolytic Therapy with Tenecteplase
	-	Activated Factor XII Provides Better Short-term Prognostic Information for a Subsequent Troponin-T Positive Event than other Biomarkers in Patients with Myocardial Infarction
	-	Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI)
Grundy P	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
Grüner S	-	Coagulation Factor XII is Essential for Arterial Thrombus Formation in Vivo
	-	Role of Integrin a2b1 in Thrombus Stabilization and Embolization
Grünewald M	-	Pregnancy of a Libanese Woman with Homozygous Protein C deficiency
	-	First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency
Guagnano MT	-	Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
	-	Insulin Resistance and Platelet Activation in Obese Women
Guanti G	-	Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations?
Guardascione M	-	Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease
Guazzaloca G	-	Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal
	-	D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
	-	Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels
	-	Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
	-	D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis
	-	Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
Gudmundsen TE	-	Long-Term Occurrence of Venous Thromboembolism after Major Joint Surgery
Guercini F	-	Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism
	-	Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Guerrero JA	-	Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A₂ Level and might Affect the Efficacy of Aspirin
	-	Antagonism of TxA₂ Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function
	-	Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic?
	-	Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder
Guerrero F	-	Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement
Guerrier G	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
Guertin S	-	Effectiveness of Recombinant Activated FVII (rFVIIa) for the Treatment of Severe Bleeding Episodes in Pediatric Patients
Guglielmini G	-	NCX-6550, a Nitric Oxide-Donating Derivative of Pravastatin, Prevents Thrombus Formation and Inhibits Intimal Thickening in Hypercholesterolemic Mice more than Pravastatin, Despite Identical Lipid Lowering
Guéguen G	-	Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Guido T	-	Protein S Multimers are Generated in vitro and do Not Bind to C4b-binding Protein: Implications for Protein S Structure-Function Analysis
Guidobono R	-	Correlation Between Compresive Ultrasonography and D Dimer Levels in Patients with Deep Venous Thrombosis
Guiffre A	-	The Circulating Progenitor in Intimal Hyperplasia: Could It Be the Fibrocyte?
	-	The Opposing Roles of Monocytes in Atherosclerosis
Guillaumon AT	-	Effects of Warfarin Administration on in vivo Revascularization in a Rat Model of Hindlimb Ischemia
Guillet B	-	Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor
	-	Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor
Guilliatt AM	-	Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
	-	Pseudo von Willebrand Disease: 2B or not 2B? Cryoprecipitate Induced Platelet Aggregation Solves Hamlet's Dilemma
Guilliatt A	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Guillin MC	-	Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
Guillo P	-	Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study)
Guillonneau S	-	The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women
Guimarães DAM	-	Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients
Guimarães AHC	-	Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Pancreatic Carboxypeptidase B (CPB) on the Capillary Tube Formation in an in vitro Angiogenesis System
Guimarães DAM	-	Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
Guinto ER	-	Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
Guinto ER	-	Activated Factor XI Cleaves von Willebrand Factor in the A2 Domain: A Possible Role of FXIa Along with ADAMTS13 in the Etiology of TTP
Guinto E	-	ADAMTS13 Forms a Stable Complex with Coagulation Factors XI (FXI) and Activated FXI (FXIa): Quantitation of ADAMTS13/FXI Complexes in Normal Plasma and in Thrombotic Thrombocytopenia Purpura (TTP) Plasmas Using a New ELISA
Guldiken S	-	The Relationship between Pro-Inflammatory Cytokine Levels and Fibrinolytic System in Simple Obese Patients
Gun-Munro J	-	Measurement of EQA Performance of a Whole Blood D-Dimer Assay Using Lyophilized Plasma
Gunneman T	-	Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
	-	Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
Gunnemann T	-	Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System
Günther JU	-	The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Gunther KE	-	Regular Plasma Infusion Allows Successful Pregnancy despite Thrombotic Thrombocytopaenic Purpura Relapse in First Trimester
Guo R	-	Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Guo Y	-	Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors
	-	Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance
Guo Y	-	Cell Death Induced by Fibrin-Degradation Products
Gupta PK	-	Gene Conversions Are a Common Cause of von Willebrand Disease
Gurbel PA	-	Thromboelastography Is a Useful Predictor of Stent Thrombosis
Gurbel PA	-	High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study
Gurbel P	-	Viral Respiratory Tract Infections Increase Platelet Reactivity and Activation – an Explanation for Higher Rates of MyocardialInfarction and Stroke during Viral Illness
Gurbel PA	-	Clopidogrel Effect on Platelet Reactivity in Patients with Stent Thrombosis: Results of the CREST Study
	-	The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting
Gurbel PA	-	Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting
	-	Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance
Gurfinkel EP	-	Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
Gursel T	-	Retrospective Open Multicenter Study on the Efficacy and Safety of Activated Prothrombin Complex (Feiba®) in Haemorrhage and Surgical Interventions in Haemophilia Patients with Inhibitor and in Patients with Rare Bleeding Disorders in Turkey
Guschlbauer E	-	Evaluation of the Automated Coagulation Analyzer ACL TOP^TM
Gustafsson KM	-	Prothrombin Complex Methods Are Most Sensitive for Prothrombin, Less for Factor VII and Much Less for Factor X, But the Contribution of the Different Factors, Vitamin K Dependent and Non-dependent Factors, Varies a Lot between Reagents
GustafssonMånsson-Broberg TA	-	Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia
Gutgobert C	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
	-	Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden
	-	Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients
Guyer K	-	Thromboelastography Is a Useful Predictor of Stent Thrombosis
	-	Dose-Dependent Clopidogrel-Atorvastatin Drug–Drug Interaction Determined by Light Transmission Aggregometry
Guyer K	-	Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients
Guyer K	-	Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting
Guzal M	-	Thomboembolic Complications and Pathogenetic Role of Nitric Oxide in Patients with Chronic Heart Failure
Gézsi A	-	Modeling VWF Catabolism Predicts the Multimer Pattern and Subunit Degradation in VWD Vicenza, Type 1, Type 2A, and Healthy Controls after DDAVP Infusion